Everything GLP-1
Everything GLP-1" is a podcast to discuss just that. GLP-1s are everywhere, but there's no one, great place to get quality, professional opinions that can help inform your health journey. Join Dr.
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 2, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 8, 2026
Latest episodes
Counseling Patients Through Weight Loss and Mental Health with Cassidy Palmisano (opens the original)
Read excerpt
In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Cassidy Palmisano, a licensed professional counselor with a master's in clinical mental health counseling and roughly a decade of experience across inpatient and outpatient settings, to examine the relationship between obesity and mental health. Rather than treating weight loss and emotional wellbeing as separate concerns, the conversation frames them as deeply interconnected, with GLP-1 medications acting as a tool that removes long
Managing GLP-1 Side Effects Through Smart Eating with Amy Davis (opens the original)
Read excerpt
In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Amy Davis, a registered dietitian with ten years of experience helping patients optimize their nutrition and health, to explore how food choices shape outcomes for people on GLP-1 medications. Nutrition is often treated as an afterthought once a prescription is written, but the conversation makes clear that what patients eat directly influences muscle preservation, side effect management, and long-term success. Amy explains her three
Why Sourcing and Testing Matter in Compounded Peptides | Trey (Joseph) Pierre (opens the original)
Read excerpt
In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Trey (Joseph) Pierre, who heads Galleria Medical Pharmacy in New Orleans and ranks among the top compounding pharmacists in the Gulf South, to trace how compounding has evolved from mortar-and-pestle apothecary work into a heavily regulated science built on sterility testing, potency verification, and sourcing from FDA-registered facilities. Trey explains how oversight from the United States Pharmacopeia reshaped the industry after e
Inside the Regulatory Battle Shaping Compounded GLP-1 Access | Scott Brunner (opens the original)
Read excerpt
In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Scott Brunner, CEO and President of the Alliance for Pharmacy Compounding, to examine how pharmacy compounding has shaped patient access during the GLP-1 shortage era. Rather than framing compounding as a workaround, Brunner explains how it operates within a rigorous, multilayered regulatory system involving the FDA, USP standards, and state boards of pharmacy. Together, they discuss how drug makers have sometimes conflated legitimat
Everything You Need to Know About Compounded GLP-1s in 2026 | Karla Palmer (opens the original)
Read excerpt
Compounded GLP-1 medications have become one of the most talked-about topics in healthcare, but there’s also a tremendous amount of confusion surrounding their legality, safety, and role in patient care. In this episode of Everything GLP-1, Dr. Tom Lavin sits down with Karla Palmer, one of the nation’s leading FDA and DEA regulatory attorneys, to break through the misinformation and explain what patients need to know. With more than three decades of experience advising pharmacies, manufacturers,
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.